Effects of creatine supplementation on nutritional status, muscle function and quality of life in patients with colorectal cancer -: A double blind randomised controlled trial

被引:37
|
作者
Norman, Kristina
Stuebler, Dominik
Baier, Peter
Schuetz, Tanja
Ocran, Kenneth
Holm, Eggert
Lochs, Herbert
Pirlich, Matthias [1 ]
机构
[1] Univ Med Berlin, Charite, Med Klin Schwerpunkt Gastroenterol Hepatol & Endo, D-10098 Berlin, Germany
[2] Univ Klinikum Mannheim, Med Univ Klin 2, Mannheim, Germany
关键词
creatine; colorectal cancer; cachexia; chemotherapy; bioimpedance parameters; phase angle;
D O I
10.1016/j.clnu.2006.01.014
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background & aim: Nutritional status frequently deteriorates during chemotherapy in cancer. This is associated with a poor outcome. Since creatine supplementation has shown promising results in various diseases, we investigated the effects of creatine on nutritional status in patients with colorectal cancer undergoing chemotherapy. Methods: Thirty patients with colorectal cancer undergoing chemotherapy were randomised to receive either creatine (n = 16) or placebo (n = 15) for 8 weeks. Body composition was determined with bioelectrical impedance analysis; muscle function by hand grip, hip flexion and knee extension strength and quality of life (QoL) was assessed by the QLQ30 questionnaire. Results: Neither muscle function, body cell mass (BCM) nor QoL improved, but phase angle, a marker of BCM and cell integrity, increased significantly in the intervention patients (5.3 +/- 0.3 degrees to 5.4 +/- 0.2 degrees, P = 0.030). Evaluating patients with different chemotherapy regimens, however, only intervention patients undergoing less aggressive chemotherapy were shown to benefit, increasing phase angle (5.11 +/- 0.22 degrees to 5.51 +/- 0.30 degrees, P=0.043) as well as BCM (27.22+/-2.85 to 29.60 +/- 3.54 kg, P = 0.043). Conclusion: Creatine failed to improve muscle mass or function and QoL in colorectal cancer patients but improved bioimpedance parameters that are predictive of poor outcome. Creatine might therefore be useful in patients with milder chemotherapy in order to maintain or increase BCM whereas patients undergoing aggressive chemotherapy however are not likely to benefit. (C) 2006 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
引用
收藏
页码:596 / 605
页数:10
相关论文
共 50 条
  • [31] A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer
    S H Lim
    T W Kim
    Y S Hong
    S-W Han
    K-H Lee
    H J Kang
    I G Hwang
    J Y Lee
    H S Kim
    S T Kim
    J Lee
    J O Park
    S H Park
    Y S Park
    H Y Lim
    S-H Jung
    W K Kang
    British Journal of Cancer, 2015, 113 : 1421 - 1426
  • [32] Effects of dietary supplementation with medicinal fungus in fasting glycemia levels of patients with colorectal cancer: a randomized, double-blind, placebo-controlled clinical study
    Fortes, R. C.
    Recova, V. L.
    Melo, A. L.
    Novaes, M. R. C. G.
    NUTRICION HOSPITALARIA, 2008, 23 (06) : 591 - 598
  • [33] Methotrimeprazine versus haloperidol in palliative care patients with cancer-related nausea: a randomised, double-blind controlled trial
    Hardy, Janet Rea
    Skerman, Helen
    Philip, Jennifer
    Good, Phillip
    Currow, David C.
    Mitchell, Geoffrey
    Yates, Patsy
    BMJ OPEN, 2019, 9 (09):
  • [34] Creatine supplementation does not promote additional effects on inflammation and insulin resistance in older adults: A pilot randomized, double-blind, placebo-controlled trial
    Oliveira, Camila L. P.
    Mello Antunes, Barbara de Moura
    Gomes, Aline Corado
    Lira, Fabio Santos
    Pimentel, Gustavo Duarte
    Boule, Normand G.
    Mota, Joao Felipe
    CLINICAL NUTRITION ESPEN, 2020, 38 : 94 - 98
  • [35] Diagnosing deficits in quality of life and providing tailored therapeutic options: Results of a randomised trial in 220 patients with colorectal cancer
    Klinkhammer-Schalke, Monika
    Steinger, Brunhilde
    Koller, Michael
    Zeman, Florian
    Fuerst, Alois
    Gumpp, Julia
    Obermaier, Robert
    Piso, Pompiliu
    Lindberg-Scharf, Patricia
    EUROPEAN JOURNAL OF CANCER, 2020, 130 : 102 - 113
  • [36] Effects of Perioperative Oral Nutrition Supplementation in Malaysian Patients Undergoing Elective Surgery for Breast and Colorectal Cancers-A Randomised Controlled Trial
    Wong, Ting Xuan
    Wong, Wei Xiang
    Chen, Seong Ting
    Ong, Shu Hwa
    Shyam, Sangeetha
    Ahmed, Nurzarina
    Hamdan, Khairul Hazim
    Awang, Raflis Ruzairee
    Ibrahim, Mohd Razali
    Palayan, Kandasami
    Chee, Winnie Siew Swee
    NUTRIENTS, 2022, 14 (03)
  • [37] Safety and efficacy of creatine supplementation in juvenile dermatomyositis: a randomized double-blind placebo-controlled cross-over trial
    Adriana Sallum
    Marina Solis
    Ana Paula Hayashi
    Guilherme Artioli
    Marcelo Sapienza
    Maria Otaduy
    Ana Pinto
    Clóvis Silva
    Rosa Pereira
    Bruno Gualano
    Pediatric Rheumatology, 12 (Suppl 1)
  • [38] Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial
    Rae, C
    Digney, AL
    McEwan, SR
    Bates, TC
    PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2003, 270 (1529) : 2147 - 2150
  • [39] The effect of nutritional counseling on muscle mass and treatment outcome in patients with metastatic colorectal cancer undergoing chemotherapy: A randomized controlled trial
    van der Werf, A.
    Langius, J. A. E.
    Beeker, A.
    ten Tije, A. J.
    Vulink, A. J.
    Haringhuizen, A.
    Berkhof, J.
    van der Vliet, H. J.
    Verheul, H. M. W.
    de van der Schueren, M. A. E.
    CLINICAL NUTRITION, 2020, 39 (10) : 3005 - 3013
  • [40] The prognostic value of WHO performance status in relation to quality of life in advanced colorectal cancer patients
    Mol, L.
    Ottevanger, P. B.
    Koopman, M.
    Punt, C. J. A.
    EUROPEAN JOURNAL OF CANCER, 2016, 66 : 138 - 143